Fund your studies with confidence, knowing enrollment is planned and monitored in real time.
We at TrialCanopy bring all your recruitment vendors, sites and patient events onto a single platform, and grow your network with you, so we can help you plan and execute every study, and reward the partners who deliver. We reward them on real performance, and keep them ahead of what is coming down your pipeline, so they are always ready to adapt their capacity and deliver.
THE JOB
You own the enrollment number. You don't control what drives it.
Your name is on the timeline, but the referrals sit with vendors, the screening calls sit with sites, and the reporting sits with your CRO. The job was never more dashboards. It is seeing enrollment risk while there is still time to act, and moving budget to what is working. That is the job TrialConX does with you.
TrialConX fits you if
- →You want to know which sites and vendors will deliver before you commit budget.
- →You want to see which spend led to a participant who enrolled and stayed.
- →You believe sites doing the work should be paid when they deliver, not months later.
We are probably not your next step if
- →Your studies run through a handful of sites you know well.
- →You have decided your CRO should own the whole recruitment journey.
If that changes, we are here.
Recruitment and retention are among the largest controllable line items in your trial,1 and the least visible.
Vendors are paid for leads, not results.
Recruitment vendors are paid per referral, not for how many qualify, enroll and stay. They focus on sending more referrals, even when few become enrolled participants. You end up paying for volume that doesn't convert.
Sites are paid too slowly to stay focused.
Nearly 80% of sites hold less than six months of operating capital. 10% hold less than one month, which puts them one late payment from exiting the industry. When cash is that tight, sites prioritize the work that pays faster.2
The data arrives too late to act on.
By the time reporting shows what worked, the budget's spent and the timeline's already slipped.
The real issue is not intent. It's the gaps between organizations.
Everyone wants participants enrolled. The problem is structural: separate systems, no shared performance view, payments that don't reward the right actions fast enough.
We build your network for you.
We load your historic site and vendor data, then assemble and rank a network of sites and vendors matched to your protocol, against your active and planned pipeline. It is proven on real performance, and it compounds study after study.
Every referral that qualifies reaches a booked screening visit.
The phone screening script is built into the participant record, so the call happens consistently across every site in your network. Fewer referrals fall between the cracks, and the conversion rate from referral to screened improves across your whole study.
Participants who enroll need to complete.
Automated reminders, self-rescheduling, and calendar sync reduce no-shows. No-show risk is scored and surfaced live, so sites can act before a visit is missed. Your network stays focused on retention, not just getting participants through the door.
We measure every participant journey for you.
We track every participant journey end to end, and work with your sites to make sure everything is connected and feeding back live. So you always have the enrollment data to make budget and timeline decisions with confidence.
We make sure your partners are paid on time.
Fast, milestone-based payment — referral, pre-screening, enrollment, first dose — is the single biggest thing that keeps a network engaged on your study. We handle it for you, so partners stay focused instead of chasing cash.
One CRM across every study.
Ask questions in plain English, across your whole portfolio, and act on the answer in one click.
Attribution from spend all the way to a participant who completes the study.
TrialCanopy sits across all your studies at once, combining deep integrations with the stack you already have, hands-on site engagement, and our own data models. Every participant journey is measured from first dollar spent to last participant, last visit, and the chance to keep each participant engaged is shared with your sites in real time. Every lesson compounds into your next study, so the network keeps learning.
Works with the stack you or your sites already have: RealTime, Advarra, Veeva, CRIO, EDC.
Run a Spend DiagnosticThe whole platform
See everything the platform can do.
You have seen why this matters to you. The platform overview walks through every key feature, from the first referral to enrollment, retention and payment.
Explore the platformHow it works
Over half of studies extend their enrollment timeline.3 Setup takes two to three weeks.
How long depends on how many sites and active studies are in scope, and on commitment to putting the system in. Where that commitment is there, two to three weeks is realistic. We would rather say that plainly than quote you a number we cannot hold.
We take the data, however it arrives.
Your recruitment vendors, your sites, their teams and their CRMs. Structured or messy, in whatever format they hold it. That includes the candidates who are not on a study yet, not only the ones who are.
We connect every site and centralize it.
CRIO and whatever else your sites already run. One calendar, one participant journey, one place the tracking lives, across the whole network. Without this there is nothing to detect risk against.
We stay in it.
We train the site teams, set up the engagement automation, support study setup, and keep finding referral partners so the pipeline does not run dry.
We go and do this at every site. Your sites are not asked to run a project.
The point is not the three weeks. It is that from then on you can see enrollment risk across every site while there is still time to act on it.
We all do well when participants enroll.
Do you know which sites and vendors will deliver on your active studies, let alone your next ones? Can you see where participants are most likely to miss their next visit, before they do? If not, that is exactly the gap we close.
¹ US federal analysis of negotiated trial contracts puts patient recruitment, patient retention, site recruitment and site retention at a combined 18 to 20% of per-study costs in Phases II to IV (ASPE, 2014).² SCRS 2023 Site Landscape Survey, approximately 550 site respondents. 51% of sites report monthly payment agreements, but sites report not receiving monthly payments. 23% say 31 to 40% of their invoices are already more than 90 days late.³ Tufts CSDD analysis of 151 global clinical trials: 47% completed enrollment within the planned timeline, 53% extended, and one in six took more than twice as long as planned (Applied Clinical Trials, Enrollment Performance: Weighing the Facts).